Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Journal of Neuro-Oncology
|
November 17, 2023
The ruse of reduction - comment to Zeng et al
Vincent Cassidy, Ryan J Brisson
International Journal of Radiation Oncology, Biology, Physics
|
February 23, 2023
Who Knows When it is Right Under Your Nose? A Case of Cutaneous Squamous Cell Carcinoma with Involvement of the Nasal Vestibule
Ryan J Brisson, Adam L Holtzman
Practical Radiation Oncology
|
August 26, 2024
Survival (Time-To-Event) Curve Names and Endpoints
Vincent D Cassidy, Ryan J Brisson, Robert J Amdur
Technical Innovations & Patient Support in Radiation Oncology
|
September 22, 2022
The landscape of digital resources in radiation oncology
Matthew M Culbert, Ryan J Brisson, Oluwadamilola T Oladeru
Health Science Reports
|
May 10, 2021
The role of chemotherapy in the management of olfactory neuroblastoma: A 40-year surveillance, epidemiology, and end results registry study
Ryan J Brisson, Thomas J Quinn, Rohan L Deraniyagala
Brain and Cognition
|
December 6, 2018
The time course of semantic and relational processing during verbal analogical reasoning
Matthew J Kmiecik, Ryan J Brisson, Robert G Morrison
Cureus
|
December 1, 2017
Three-Dimensional Computed Tomography Reconstruction for Revision Parathyroidectomy
Navdeep R Sayal, Ryan J Brisson, Kenneth Richey, et al.
Cureus
|
May 16, 2017
Pilot Study of 99mTc-labeled Ethylene Dicysteine Deoxyglucose SPECT-CT Imaging in Treatment Response Evaluation in Patients with Locally Advanced Head and Neck Cancer
Daniel T Ginat, Charles Westiin, Ryan J Brisson, et al.
American Journal of Clinical Oncology
|
February 29, 2024
Flap Reconstruction Results in Longer Overall Treatment Time in Patients Treated With Surgery and Adjuvant Radiotherapy for Carcinoma of the Oral Cavity and Larynx
Nicolette R Drescher, Tayna Latortue, Ryan J Brisson, et al.
Head & Neck
|
September 6, 2019
A pilot study of the pan-class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent or metastatic head and neck cancer
Ryan J Brisson, Sara Kochanny, Saba Arshad, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Journal of Neuro-Oncology
|
November 17, 2023
The ruse of reduction - comment to Zeng et al
Vincent Cassidy, Ryan J Brisson
International Journal of Radiation Oncology, Biology, Physics
|
February 23, 2023
Who Knows When it is Right Under Your Nose? A Case of Cutaneous Squamous Cell Carcinoma with Involvement of the Nasal Vestibule
Ryan J Brisson, Adam L Holtzman
Practical Radiation Oncology
|
August 26, 2024
Survival (Time-To-Event) Curve Names and Endpoints
Vincent D Cassidy, Ryan J Brisson, Robert J Amdur
Technical Innovations & Patient Support in Radiation Oncology
|
September 22, 2022
The landscape of digital resources in radiation oncology
Matthew M Culbert, Ryan J Brisson, Oluwadamilola T Oladeru
Health Science Reports
|
May 10, 2021
The role of chemotherapy in the management of olfactory neuroblastoma: A 40-year surveillance, epidemiology, and end results registry study
Ryan J Brisson, Thomas J Quinn, Rohan L Deraniyagala
Brain and Cognition
|
December 6, 2018
The time course of semantic and relational processing during verbal analogical reasoning
Matthew J Kmiecik, Ryan J Brisson, Robert G Morrison
Cureus
|
December 1, 2017
Three-Dimensional Computed Tomography Reconstruction for Revision Parathyroidectomy
Navdeep R Sayal, Ryan J Brisson, Kenneth Richey, et al.
Cureus
|
May 16, 2017
Pilot Study of 99mTc-labeled Ethylene Dicysteine Deoxyglucose SPECT-CT Imaging in Treatment Response Evaluation in Patients with Locally Advanced Head and Neck Cancer
Daniel T Ginat, Charles Westiin, Ryan J Brisson, et al.
American Journal of Clinical Oncology
|
February 29, 2024
Flap Reconstruction Results in Longer Overall Treatment Time in Patients Treated With Surgery and Adjuvant Radiotherapy for Carcinoma of the Oral Cavity and Larynx
Nicolette R Drescher, Tayna Latortue, Ryan J Brisson, et al.
Head & Neck
|
September 6, 2019
A pilot study of the pan-class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent or metastatic head and neck cancer
Ryan J Brisson, Sara Kochanny, Saba Arshad, et al.
Page
of 3